Dr. Kamakshi Memorial Hospitals
Tracked across 1 events · 6 articles · First seen Sep 10, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
India's India — Drugs Controller General of India (DCGI) has approved an allogeneic bone marrow-derived mesenchymal stem cell therapy for knee osteoarthritis, marking the first time such an approved regenerative therapy enters clinical practice in…
Impact: Dr. Kamakshi Memorial Hospitals is the first center in Tamil Nadu to administer the approved stem cell therapy, enhancing its profile as a pioneer in knee preservation and regenerative orthopedics.
Sep 10, 2026 · 6 articles
70
Dr. Kamakshi Memorial Hospitals administered stem cell therapyIndia Approves Stempeutics...
60
Cipla made therapy available Dr. Kamakshi Memorial HospitalsIndia Approves Stempeutics...
ERGEN INTELLIGENCE
Track Dr. Kamakshi Memorial Hospitals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard